Your browser doesn't support javascript.
loading
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study.
Montes, Ariana; Perez-Pampin, Eva; Navarro-Sarabia, Federico; Moreira, Virginia; de la Serna, Arturo Rodríguez; Magallares, Berta; Vasilopoulos, Yiannis; Sarafidou, Theologia; Fernández-Nebro, Antonio; Ordóñez, María Del Carmen; Narváez, Javier; Cañete, Juan D; Marquez, Ana; Pascual-Salcedo, Dora; Joven, Beatriz; Carreira, Patricia; Moreno-Ramos, Manuel J; Caliz, Rafael; Ferrer, Miguel Angel; Garcia-Portales, Rosa; Blanco, Francisco J; Magro, Cesar; Raya, Enrique; Valor, Lara; Alegre-Sancho, Juan J; Balsa, Alejandro; Martin, Javier; Plant, Darren; Isaacs, John; Morgan, Ann W; Barton, Anne; Wilson, Anthony G; Gómez-Reino, Juan J; Gonzalez, Antonio.
Afiliação
  • Montes A; Laboratorio de Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria - Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain. montes.ariana81@gmail.com.
  • Perez-Pampin E; Laboratorio de Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria - Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain. eva.perez.pampin@sergas.es.
  • Navarro-Sarabia F; Rheumatology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain. federico.navarro.sarabia@gmail.com.
  • Moreira V; Rheumatology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain. virgimn@hotmail.com.
  • de la Serna AR; Rheumatology Unit, Hospital Santa Creu e San Pau, Barcelona, Spain. arturojj@hotmail.com.
  • Magallares B; Rheumatology Unit, Hospital Santa Creu e San Pau, Barcelona, Spain. berpauma@hotmail.com.
  • Vasilopoulos Y; Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece. iovasilopoulos@bio.uth.gr.
  • Sarafidou T; Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece. sarafid@bio.uth.gr.
  • Fernández-Nebro A; Servicio de Reumatología, HRU Carlos Haya, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain. afnebro@gmail.com.
  • Ordóñez Mdel C; Servicio de Reumatología, HRU Carlos Haya, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain. maricarmenoc@hotmail.com.
  • Narváez J; Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain. fjnarvaez@bellvitgehospital.cat.
  • Cañete JD; Rheumatology Unit, Hospital Clinic, Barcelona, Spain. JCANETE@clinic.ub.es.
  • Marquez A; Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain. anamaort@ipb.csic.es.
  • Pascual-Salcedo D; Department of Immunology, Instituto de Investigación Hospital Universitario La Paz, Hospital La Paz, Madrid, Spain. dpascual.hulp@salud.madrid.org.
  • Joven B; Department of Rheumatology, Hospital 12 de Octubre, Madrid, Spain. beatrizjoven@hotmail.com.
  • Carreira P; Department of Rheumatology, Hospital 12 de Octubre, Madrid, Spain. carreira@h12o.es.
  • Moreno-Ramos MJ; Department of Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain. mjmoreno1@yahoo.es.
  • Caliz R; Rheumatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain. rcalizcaliz@gmail.com.
  • Ferrer MA; Rheumatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain. ma_ferrer61@yahoo.es.
  • Garcia-Portales R; Department of Rheumatology, Hospital Virgen de la Victoria, Málaga, Spain. rosagaport@hotmail.com.
  • Blanco FJ; Rheumatology Department, Instituto de Investigacion Biomedica-Complejo Hospitalario Universitario A Coruna, A Coruna, Spain. fblagar@sergas.es.
  • Magro C; Department of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain. fblagar@sergas.es.
  • Raya E; Department of Rheumatology, Hospital Clínico San Cecilio, Granada, Spain. cesar_magro@yahoo.es.
  • Valor L; Department of Rheumatology, Hospital Clínico San Cecilio, Granada, Spain. enriraya@gmail.com.
  • Alegre-Sancho JJ; Rheumatology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain. larissa.valor@salud.madrid.org.
  • Balsa A; Department of Rheumatology, Hospital Doctor Peset, Valencia, Spain. alegre_juasan@gva.es.
  • Martin J; Department of Rheumatology, Instituto de Investigación Hospital Universitario La Paz, Hospital Universitario La Paz, Madrid, Spain. al.balsa@ser.es.
  • Plant D; Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain. martin@ipb.csic.es.
  • Isaacs J; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. Darren.Plant@manchester.ac.uk.
  • Morgan AW; Musculoskeletal Research Group, Institute of Cellular Medicine, The Medical School, Newcastle University, Newcastle, UK. john.isaacs@ncl.ac.uk.
  • Barton A; National Institute for Health Research Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, Newcastle, UK. john.isaacs@ncl.ac.uk.
  • Wilson AG; Leeds Institute of Rheumatic and Musculoskeletal Medicine, St. James's University Hospital, University of Leeds, Leeds, UK. a.w.morgan@leeds.ac.uk.
  • Gómez-Reino JJ; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. anne.barton@manchester.ac.uk.
  • Gonzalez A; Arthritis Research UK-Centre for Genetics and Genomics, The University of Manchester, Manchester, UK. anne.barton@manchester.ac.uk.
Arthritis Res Ther ; 17: 63, 2015 Mar 18.
Article em En | MEDLINE | ID: mdl-25885039

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Imunoglobulina G / Adalimumab / Infliximab Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Imunoglobulina G / Adalimumab / Infliximab Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article